PE 22 28 Peptide: TREK-1 Antidepressant For Humans? (2026)

Scientists switched off one gene in a mouse. It became immune to depression.

The gene creates a brain channel called TREK-1. PE 22-28 shuts that channel down by design.

It worked in three days for depressed mice. SSRI takes six weeks.

What Is PE 22 28?

Synthetic peptide. Seven amino acids. 22-28 is not the count of amino acids. It marks positions 22 through 28 of a longer natural peptide called spadin.

Cut spadin to those seven residues to get the strongest fragment. Called “mini-spadin” in the research. Spadin comes from a protein (NTSR3) as sortilin matures inside cells. Our body makes the parent.

Please watch the bad information circulating online.

I read that PE-22-28 is “derived from BDNF.” Some call it “a fragment of galanin.” Somebody wrote an article and says it “consists of 22 to 28 amino acids.”

All wrong!

It is a sortilin-derived heptapeptide. It blocks TREK-1. When a source gets it so remarkably wrong, distrust the rest.

How PE-22-28 Works

It blocks one channel, TREK-1. A potassium valve found in the wall of your neurons. It leaks potassium out and keeps the cell quiet. Too quiet in a depressed brain. Especially in the hippocampus and the serotonin-producing parts.

PE-22-28 plugs the valve at 0.12 nanomolar. This is a hundred times stronger than natural spadin. Potassium stops leaking. The neuron fires more smoothly. And serotonin neurons signal harder. This is the key difference from SSRIs.

SSRIs flood serotonin. It takes weeks while receptors remodel. PE-22-28 releases the brake on the serotonin neurons you already have. This is why effects show up in days.

The target was proven backward. In 2006, a French scientist deleted the TREK-1 gene in mice and published it in Nature Neuroscience. The knockout mice were depression-resistant across five models. Delete the channel, delete the depression. A paper that opened this entire field.

What The Research Shows

Depression. Mice on  PE-22-28 cut forced-swim immobility from 165 seconds to 98. Almost half. And it signals a strong antidepressant response. One dose worked in 30 minutes. Four days raised BDNF, the brain’s growth signal. Raised PSD-95 (new synapses), and grew new hippocampal neurons.

Stroke. A 2019 study in Neuropharmacology found the dose flips the effect.

0.03 µg/kg activated TREK-1 and protected brain tissue after a stroke.

3 µg/kg blocked TREK-1 and treated the depression that follows a stroke.

Beta cells (early). A 2021 study found mini-spadin protected insulin-producing pancreatic cells from death and drove their proliferation through CREB signaling. The speculative diabetes angle. Cell and animal work, nothing more.

Anxiety and focus. The claims are theory and forum reports. May help.

What it did not break (mouse). No cardiac damage. No seizures. No pain sensitization. The three failures that killed older TREK-1 drugs. It did not touch hERG, the cardiac safety channel, and stayed clean against TREK-2, TRAAK, TRESK, and TASK-1. Clean in a mouse is not automatically clean for humans. No long-term toxicology exists.

PE-22-28 vs Ketamine

PE-22-28 is the gentler design on paper, no dissociation, no clinic, no controlled-substance label. But ketamine has thousands of real patients and an FDA-approved form. PE-22-28 has zero humans. One is an idea. The other is a medicine.

Dosage

Validate human dose doesn’t exist. This is what researchers report.

• Nasal spray: 100 to 500 mcg once daily, morning. The common clinic figure is near 400 mcg. Past 600 to 800 mcg, users report the opposite of what they wanted: lethargy and a flat, switched-off mood. The brake pressed too hard.
• Injection (subcutaneous): 100 to 300 mcg a day, morning.
• Cycle: 4 to 8 weeks, then off.

Here’s the number that should bother you. Scale the mouse dose to a human by body weight, and you land near 17 micrograms. The community runs 400, about twenty-five times the dose the animal data justifies, picked by feel. Nobody knows the right human dose. Take it in the morning regardless; night dosing harms sleep.

Why It Goes Up Your Nose

People spray PE-22-28 because the target sits behind the blood-brain barrier. Swallow it and stomach enzymes shred it. Inject it and most never reaches the brain. Spray it up the nose and it travels the olfactory nerve toward brain tissue, skipping the gut and the liver’s first pass. Same logic as Selank and Semax.

Side Effects & Safety

The animal profile was clean: no cardiac problems, no seizures, no pain sensitization. But that is the entire safety record, from short rodent studies. No human safety data exists.

Community-reported, all anecdotal: nasal irritation, mild early headaches, sleep disruption if dosed late, lethargy at high doses.

One warning matters most. PE-22-28 raises serotonin signaling. Stack it on an SSRI, SNRI, MAOI, or any serotonin drug and you risk serotonin syndrome, a life-threatening reaction of racing heart, high temperature, agitation, and confusion. This is why you never quietly add a research peptide to a prescription. Medicated and curious is a conversation for your prescriber, not a forum.

Is It Legal?

Not FDA-approved. Not a controlled substance. Sold as a research chemical, “not for human use.” It was not on the FDA’s restricted Category 2 list or the July 2026 review docket. Grey zone, like most research peptides.

Tested athlete: WADA’s S0 category bans any non-approved substance by default. Treat it as banned.

How to Buy It Without Getting Robbed

The peptide is not the risk. The seller is.

It ships as lyophilized vials, roughly $50 to $130 per 10 mg, and pre-mixed nasal sprays, the easier start. Before you pay, demand a batch-specific COA: 98%+ HPLC purity, mass-spec identity, and the sequence GVSWGLR matching molecular weight 774. Sellers have shipped plain spadin or unrelated peptides under this name. The sequence on the report is how you catch the swap.

Amino Asylum? Gone. The FDA raided them in 2025 and the owners pleaded guilty. Peptide Sciences shut down in 2026. Buy only from vendors who publish real third-party reports, and vet them like any peptide source.

PE-22-28 FAQ

Conclusion

PE-22-28 is one of the cleanest ideas in antidepressant research. Find the brain’s mood brake, build a key at 0.12 nanomolar, lift the mood in days instead of weeks. In mice, it works, and it works without wrecking the heart older drugs destroyed.

In humans, it has never been tested. Not once. That is the frame, not a footnote.

The mouse felt better in three days. You are not a mouse, and depression is not a thing to experiment on alone. If you are reading this at midnight because you are hurting, the brave move is not a vial. It is telling one person who can actually help.

Chase the proof. Not the promise.

Sources: Heurteaux C et al., Nature Neuroscience 2006 (PMID 16906152); Mazella J et al., PLoS Biology 2010 (PMID 20405001); Djillani A et al., Frontiers in Pharmacology 2017 (PMID 28955242); Pietri M et al., Neuropharmacology 2019 (PMID 31325429); Daziano G et al., Pharmacological Research 2021 (PMID 33737242). Research and educational use only. PE-22-28 is not FDA-approved for human use. No human clinical trials exist. Not medical advice. If you are dealing with depression, please talk to a licensed clinician.